Cell therapy uses living cells as therapeutic agents to repair tissue, modulate immunity, replace damaged cells, or attack disease. It includes immune-cell therapies, stem-cell therapies, regenerative approaches, engineered cells, and donor- or patient-derived cell products. In biotechnology and nanomedicine, cell therapy intersects with gene editing, biomaterials, delivery systems, cell manufacturing, and tissue engineering to improve how cells are modified, expanded, targeted, and monitored.
Cell therapy matters because it offers treatment strategies that conventional small molecules or biologics cannot easily provide. Applications include cancer immunotherapy, autoimmune disease, regenerative medicine, rare genetic disorders, neurological disease, cardiovascular repair, and transplant support. Key challenges include potency, persistence, safety, immune compatibility, manufacturing scale, quality control, cost, and regulatory complexity. The field connects closely to gene therapy, regenerative medicine, tissue engineering, and biotechnology.
Conferences on cell therapy appear in biotechnology, medicine, immunology, regenerative medicine, oncology, biomanufacturing, and pharmaceutical programs. Sessions often cover CAR-T cells, stem cells, edited cells, manufacturing, clinical trials, safety, and commercialization. Tracking cell-therapy events helps researchers follow a rapidly advancing area where living cells are becoming programmable medicines.